世界の過免疫グロブリン市場予測 2020年-2025年

【英語タイトル】Global Hyperimmune Globulins Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP5875)・商品コード:LPI20AP5875
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:167
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「過免疫グロブリンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他など、用途別には、政府機関、民間部門、その他などに区分してまとめた調査レポートです。過免疫グロブリンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・過免疫グロブリンの世界市場概要(サマリー)
・過免疫グロブリンの企業別販売量・売上
・過免疫グロブリンの企業別市場シェア
・過免疫グロブリンの世界市場規模 2015年-2020年:種類別(B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他)
・過免疫グロブリンの世界市場規模 2015年-2020年:用途別(政府機関、民間部門、その他)
・過免疫グロブリンの米州市場規模(アメリカ、カナダ、メキシコなど)
・過免疫グロブリンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・過免疫グロブリンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・過免疫グロブリンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・過免疫グロブリン市場の成長要因・課題・動向
・過免疫グロブリンの世界市場予測 2021年-2025年
・過免疫グロブリンの米州市場予測(アメリカ、カナダ、メキシコなど)
・過免疫グロブリンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・過免疫グロブリンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・過免疫グロブリンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・過免疫グロブリンの世界市場予測:種類別(B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他)
・過免疫グロブリンの世界市場予測:用途別(政府機関、民間部門、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Hyperimmune Globulins market will register a 10.1% CAGR in terms of revenue, the global market size will reach $ 1958.3 million by 2025, from $ 1334.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hyperimmune Globulins business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by type, application, key manufacturers and key regions and countries.

This study considers the Hyperimmune Globulins value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Government Institutions
Private Sector
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Shanghai RAAS
Grifols
Kedrion
CBPO
Biotest
CNBG
Emergent (Cangene)
Hualan Bio
Kamada
Sichuan Yuanda Shuyang
ADMA Biologics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Hyperimmune Globulins consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Hyperimmune Globulins market by identifying its various subsegments.
Focuses on the key global Hyperimmune Globulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hyperimmune Globulins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hyperimmune Globulins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hyperimmune Globulins Consumption 2015-2025
2.1.2 Hyperimmune Globulins Consumption CAGR by Region
2.2 Hyperimmune Globulins Segment by Type
2.2.1 Hepatitis B Immunoglobulins
2.2.2 Rabies Immunoglobulins
2.2.3 Tetanus Immunoglobulins
2.2.4 Others
2.3 Hyperimmune Globulins Consumption by Type
2.3.1 Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
2.3.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2015-2020)
2.3.3 Global Hyperimmune Globulins Sale Price by Type (2015-2020)
2.4 Hyperimmune Globulins Segment by Application
2.4.1 Government Institutions
2.4.2 Private Sector
2.4.3 Other
2.5 Hyperimmune Globulins Consumption by Application
2.5.1 Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
2.5.2 Global Hyperimmune Globulins Value and Market Share by Type (2015-2020)
2.5.3 Global Hyperimmune Globulins Sale Price by Type (2015-2020)

3 Global Hyperimmune Globulins by Company
3.1 Global Hyperimmune Globulins Sales Market Share by Company
3.1.1 Global Hyperimmune Globulins Sales by Company (2018-2020)
3.1.2 Global Hyperimmune Globulins Sales Market Share by Company (2018-2020)
3.2 Global Hyperimmune Globulins Revenue Market Share by Company
3.2.1 Global Hyperimmune Globulins Revenue by Company (2018-2020)
3.2.2 Global Hyperimmune Globulins Revenue Market Share by Company (2018-2020)
3.3 Global Hyperimmune Globulins Sale Price by Company
3.4 Global Hyperimmune Globulins Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Hyperimmune Globulins Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Hyperimmune Globulins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Hyperimmune Globulins by Regions
4.1 Hyperimmune Globulins by Regions
4.2 Americas Hyperimmune Globulins Consumption Growth
4.3 APAC Hyperimmune Globulins Consumption Growth
4.4 Europe Hyperimmune Globulins Consumption Growth
4.5 Middle East & Africa Hyperimmune Globulins Consumption Growth

5 Americas
5.1 Americas Hyperimmune Globulins Consumption by Countries
5.1.1 Americas Hyperimmune Globulins Consumption by Countries (2015-2020)
5.1.2 Americas Hyperimmune Globulins Value by Countries (2015-2020)
5.2 Americas Hyperimmune Globulins Consumption by Type
5.3 Americas Hyperimmune Globulins Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Hyperimmune Globulins Consumption by Regions
6.1.1 APAC Hyperimmune Globulins Consumption by Regions (2015-2020)
6.1.2 APAC Hyperimmune Globulins Value by Regions (2015-2020)
6.2 APAC Hyperimmune Globulins Consumption by Type
6.3 APAC Hyperimmune Globulins Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Hyperimmune Globulins by Countries
7.1.1 Europe Hyperimmune Globulins Consumption by Countries (2015-2020)
7.1.2 Europe Hyperimmune Globulins Value by Countries (2015-2020)
7.2 Europe Hyperimmune Globulins Consumption by Type
7.3 Europe Hyperimmune Globulins Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Hyperimmune Globulins by Countries
8.1.1 Middle East & Africa Hyperimmune Globulins Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Hyperimmune Globulins Value by Countries (2015-2020)
8.2 Middle East & Africa Hyperimmune Globulins Consumption by Type
8.3 Middle East & Africa Hyperimmune Globulins Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hyperimmune Globulins Distributors
10.3 Hyperimmune Globulins Customer

11 Global Hyperimmune Globulins Market Forecast
11.1 Global Hyperimmune Globulins Consumption Forecast (2021-2025)
11.2 Global Hyperimmune Globulins Forecast by Regions
11.2.1 Global Hyperimmune Globulins Forecast by Regions (2021-2025)
11.2.2 Global Hyperimmune Globulins Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hyperimmune Globulins Forecast by Type
11.8 Global Hyperimmune Globulins Forecast by Application

12 Key Players Analysis
12.1 CSL Behring
12.1.1 Company Information
12.1.2 Hyperimmune Globulins Product Offered
12.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Behring Latest Developments
12.2 Shanghai RAAS
12.2.1 Company Information
12.2.2 Hyperimmune Globulins Product Offered
12.2.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Shanghai RAAS Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Hyperimmune Globulins Product Offered
12.3.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Kedrion
12.4.1 Company Information
12.4.2 Hyperimmune Globulins Product Offered
12.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Kedrion Latest Developments
12.5 CBPO
12.5.1 Company Information
12.5.2 Hyperimmune Globulins Product Offered
12.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CBPO Latest Developments
12.6 Biotest
12.6.1 Company Information
12.6.2 Hyperimmune Globulins Product Offered
12.6.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Biotest Latest Developments
12.7 CNBG
12.7.1 Company Information
12.7.2 Hyperimmune Globulins Product Offered
12.7.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CNBG Latest Developments
12.8 Emergent (Cangene)
12.8.1 Company Information
12.8.2 Hyperimmune Globulins Product Offered
12.8.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Emergent (Cangene) Latest Developments
12.9 Hualan Bio
12.9.1 Company Information
12.9.2 Hyperimmune Globulins Product Offered
12.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Hualan Bio Latest Developments
12.10 Kamada
12.10.1 Company Information
12.10.2 Hyperimmune Globulins Product Offered
12.10.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Kamada Latest Developments
12.11 Sichuan Yuanda Shuyang
12.11.1 Company Information
12.11.2 Hyperimmune Globulins Product Offered
12.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sichuan Yuanda Shuyang Latest Developments
12.12 ADMA Biologics
12.12.1 Company Information
12.12.2 Hyperimmune Globulins Product Offered
12.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 ADMA Biologics Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Hyperimmune Globulins Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Hepatitis B Immunoglobulins
Table 5. Major Players of Rabies Immunoglobulins
Table 6. Major Players of Tetanus Immunoglobulins
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 10. Global Hyperimmune Globulins Revenue by Type (2015-2020) ($ million)
Table 11. Global Hyperimmune Globulins Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Hyperimmune Globulins Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 15. Global Hyperimmune Globulins Value by Application (2015-2020)
Table 16. Global Hyperimmune Globulins Value Market Share by Application (2015-2020)
Table 17. Global Hyperimmune Globulins Sale Price by Application (2015-2020)
Table 18. Global Hyperimmune Globulins Sales by Company (2017-2019) (K Units)
Table 19. Global Hyperimmune Globulins Sales Market Share by Company (2017-2019)
Table 20. Global Hyperimmune Globulins Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Hyperimmune Globulins Revenue Market Share by Company (2017-2019)
Table 22. Global Hyperimmune Globulins Sale Price by Company (2017-2019)
Table 23. Global Hyperimmune Globulins Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Hyperimmune Globulins Products Offered
Table 25. Hyperimmune Globulins Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Hyperimmune Globulins Consumption by Regions 2015-2020 (K Units)
Table 27. Global Hyperimmune Globulins Consumption Market Share by Regions 2015-2020
Table 28. Global Hyperimmune Globulins Value by Regions 2015-2020 ($ Millions)
Table 29. Global Hyperimmune Globulins Value Market Share by Regions 2015-2020
Table 30. Americas Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 32. Americas Hyperimmune Globulins Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Hyperimmune Globulins Value Market Share by Countries (2015-2020)
Table 34. Americas Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 35. Americas Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 36. Americas Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 37. Americas Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 38. APAC Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 40. APAC Hyperimmune Globulins Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Hyperimmune Globulins Value Market Share by Regions (2015-2020)
Table 42. APAC Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 43. APAC Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 44. APAC Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 45. APAC Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 46. Europe Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 48. Europe Hyperimmune Globulins Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Hyperimmune Globulins Value Market Share by Countries (2015-2020)
Table 50. Europe Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 51. Europe Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 52. Europe Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 53. Europe Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Hyperimmune Globulins Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Hyperimmune Globulins Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Hyperimmune Globulins Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Hyperimmune Globulins Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Hyperimmune Globulins Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Table 62. Hyperimmune Globulins Distributors List
Table 63. Hyperimmune Globulins Customer List
Table 64. Global Hyperimmune Globulins Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Hyperimmune Globulins Consumption Market Forecast by Regions
Table 66. Global Hyperimmune Globulins Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Hyperimmune Globulins Value Market Share Forecast by Regions
Table 68. Global Hyperimmune Globulins Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Hyperimmune Globulins Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Hyperimmune Globulins Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Hyperimmune Globulins Value Market Share Forecast by Type (2021-2025)
Table 72. Global Hyperimmune Globulins Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Hyperimmune Globulins Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Hyperimmune Globulins Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Hyperimmune Globulins Value Market Share Forecast by Application (2021-2025)
Table 76. CSL Behring Product Offered
Table 77. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 78. CSL Behring Main Business
Table 79. CSL Behring Latest Developments
Table 80. CSL Behring Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 81. Shanghai RAAS Product Offered
Table 82. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 83. Shanghai RAAS Main Business
Table 84. Shanghai RAAS Latest Developments
Table 85. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 86. Grifols Product Offered
Table 87. Grifols Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 88. Grifols Main Business
Table 89. Grifols Latest Developments
Table 90. Grifols Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 91. Kedrion Product Offered
Table 92. Kedrion Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 93. Kedrion Main Business
Table 94. Kedrion Latest Developments
Table 95. Kedrion Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 96. CBPO Product Offered
Table 97. CBPO Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 98. CBPO Main Business
Table 99. CBPO Latest Developments
Table 100. CBPO Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 101. Biotest Product Offered
Table 102. Biotest Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 103. Biotest Main Business
Table 104. Biotest Latest Developments
Table 105. Biotest Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 106. CNBG Product Offered
Table 107. CNBG Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 108. CNBG Main Business
Table 109. CNBG Latest Developments
Table 110. CNBG Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Emergent (Cangene) Product Offered
Table 112. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 113. Emergent (Cangene) Main Business
Table 114. Emergent (Cangene) Latest Developments
Table 115. Emergent (Cangene) Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 116. Hualan Bio Product Offered
Table 117. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 118. Hualan Bio Main Business
Table 119. Hualan Bio Latest Developments
Table 120. Hualan Bio Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 121. Kamada Product Offered
Table 122. Kamada Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 123. Kamada Main Business
Table 124. Kamada Latest Developments
Table 125. Kamada Basic Information, Company Total Revenue (in $ million), Hyperimmune Globulins Manufacturing Base, Sales Area and Its Competitors
Table 126. Sichuan Yuanda Shuyang Product Offered
Table 127. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 128. Sichuan Yuanda Shuyang Main Business
Table 129. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Sichuan Yuanda Shuyang Latest Developments
Table 131. ADMA Biologics Product Offered
Table 132. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 133. ADMA Biologics Main Business
Table 134. ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. ADMA Biologics Latest Developments
List of Figures
Figure 1. Picture of Hyperimmune Globulins
Figure 2. Hyperimmune Globulins Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Hyperimmune Globulins Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Hyperimmune Globulins Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hepatitis B Immunoglobulins
Figure 7. Product Picture of Rabies Immunoglobulins
Figure 8. Product Picture of Tetanus Immunoglobulins
Figure 9. Product Picture of Others
Figure 10. Global Hyperimmune Globulins Consumption Market Share by Type (2015-2020)
Figure 11. Global Hyperimmune Globulins Value Market Share by Type (2015-2020)
Figure 12. Hyperimmune Globulins Consumed in Government Institutions
Figure 13. Global Hyperimmune Globulins Market: Government Institutions (2015-2020) (K Units)
Figure 14. Global Hyperimmune Globulins Market: Government Institutions (2015-2020) ($ Millions)
Figure 15. Hyperimmune Globulins Consumed in Private Sector
Figure 16. Global Hyperimmune Globulins Market: Private Sector (2015-2020) (K Units)
Figure 17. Global Hyperimmune Globulins Market: Private Sector (2015-2020) ($ Millions)
Figure 18. Hyperimmune Globulins Consumed in Other
Figure 19. Global Hyperimmune Globulins Market: Other (2015-2020) (K Units)
Figure 20. Global Hyperimmune Globulins Market: Other (2015-2020) ($ Millions)
Figure 21. Global Hyperimmune Globulins Consumption Market Share by Application (2015-2020)
Figure 22. Global Hyperimmune Globulins Value Market Share by Application (2015-2020)
Figure 23. Global Hyperimmune Globulins Sales Market Share by Company in 2017
Figure 24. Global Hyperimmune Globulins Sales Market Share by Company in 2019
Figure 25. Global Hyperimmune Globulins Revenue Market Share by Company in 2017
Figure 26. Global Hyperimmune Globulins Revenue Market Share by Company in 2019
Figure 27. Global Hyperimmune Globulins Sale Price by Company in 2019
Figure 28. Global Hyperimmune Globulins Consumption Market Share by Regions 2015-2020
Figure 29. Global Hyperimmune Globulins Value Market Share by Regions 2015-2020
Figure 30. Americas Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 31. Americas Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 32. APAC Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 33. APAC Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 34. Europe Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 35. Europe Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Hyperimmune Globulins Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Hyperimmune Globulins Value 2015-2020 ($ Millions)
Figure 38. Americas Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 39. Americas Hyperimmune Globulins Value Market Share by Countries in 2019
Figure 40. Americas Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 41. Americas Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 42. United States Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 43. United States Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 49. APAC Hyperimmune Globulins Value Market Share by Regions in 2019
Figure 50. APAC Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 51. APAC Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 52. China Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 53. China Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 60. India Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 61. India Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 65. Europe Hyperimmune Globulins Value Market Share by Countries in 2019
Figure 66. Europe Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 67. Europe Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 68. Germany Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 70. France Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 71. France Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 72. UK Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 73. UK Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 78. Spain Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 79. Spain Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Hyperimmune Globulins Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Hyperimmune Globulins Consumption Market Share by Application in 2019
Figure 84. Egypt Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Hyperimmune Globulins Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Hyperimmune Globulins Value Growth 2015-2020 ($ Millions)
Figure 94. Global Hyperimmune Globulins Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Hyperimmune Globulins Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 97. Americas Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 98. APAC Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 99. APAC Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 100. Europe Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 101. Europe Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 104. United States Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 105. United States Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 106. Canada Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 107. Canada Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 108. Mexico Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 109. Mexico Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 110. Brazil Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 111. Brazil Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 112. China Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 113. China Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 114. Japan Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 115. Japan Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 116. Korea Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 117. Korea Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 120. India Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 121. India Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 122. Australia Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 123. Australia Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 124. Germany Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 125. Germany Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 126. France Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 127. France Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 128. UK Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 129. UK Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 130. Italy Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 131. Italy Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 132. Russia Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 133. Russia Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 134. Spain Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 135. Spain Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 136. Egypt Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 137. Egypt Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 138. South Africa Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 139. South Africa Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 140. Israel Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 141. Israel Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 142. Turkey Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 143. Turkey Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Hyperimmune Globulins Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Hyperimmune Globulins Value 2021-2025 ($ Millions)
Figure 146. CSL Behring Hyperimmune Globulins Market Share (2018-2020)
Figure 147. Shanghai RAAS Hyperimmune Globulins Market Share (2018-2020)
Figure 148. Grifols Hyperimmune Globulins Market Share (2018-2020)
Figure 149. Kedrion Hyperimmune Globulins Market Share (2018-2020)
Figure 150. CBPO Hyperimmune Globulins Market Share (2018-2020)
Figure 151. Biotest Hyperimmune Globulins Market Share (2018-2020)
Figure 152. CNBG Hyperimmune Globulins Market Share (2018-2020)
Figure 153. Emergent (Cangene) Hyperimmune Globulins Market Share (2018-2020)
Figure 154. Hualan Bio Hyperimmune Globulins Market Share (2018-2020)
Figure 155. Kamada Hyperimmune Globulins Market Share (2018-2020)
Figure 156. Sichuan Yuanda Shuyang Hyperimmune Globulins Market Share (2018-2020)
Figure 157. ADMA Biologics Hyperimmune Globulins Market Share (2018-2020)


★調査レポート[世界の過免疫グロブリン市場予測 2020年-2025年] (コード:LPI20AP5875)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の過免疫グロブリン市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆